QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
NYSEAMERICAN:ELMD

Electromed Stock Forecast, Price & News

$12.65
-0.12 (-0.94%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$12.50
$12.80
50-Day Range
N/A
52-Week Range
$8.98
$13.85
Volume
17,521 shs
Average Volume
13,595 shs
Market Capitalization
$108.41 million
P/E Ratio
50.60
Dividend Yield
N/A
Beta
0.65
30 days | 90 days | 365 days | Advanced Chart
Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.


Electromed logo

About Electromed

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Headlines

See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ELMD
Previous Symbol
NYSEMKT:ELMD
Employees
120
Year Founded
N/A

Sales & Book Value

Annual Sales
$35.76 million
Cash Flow
$0.34 per share
Book Value
$3.75 per share

Profitability

Net Income
$2.36 million
Pretax Margin
8.06%

Debt

Price-To-Earnings

Miscellaneous

Free Float
6,282,000
Market Cap
$108.41 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/09/2021
Today
1/24/2022
Next Earnings (Estimated)
2/07/2022
Fiscal Year End
6/30/2022

MarketRank

Overall MarketRank

2.23 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

Is Electromed a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Electromed stock.
View analyst ratings for Electromed
or view top-rated stocks.

How has Electromed's stock been impacted by COVID-19 (Coronavirus)?

Electromed's stock was trading at $9.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ELMD stock has increased by 36.2% and is now trading at $12.65.
View which stocks have been most impacted by COVID-19
.

When is Electromed's next earnings date?

Electromed is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Electromed
.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) issued its earnings results on Tuesday, November, 9th. The medical equipment provider reported $0.05 EPS for the quarter, missing the Zacks' consensus estimate of $0.06 by $0.01. The medical equipment provider earned $10 million during the quarter, compared to analysts' expectations of $9 million. Electromed had a trailing twelve-month return on equity of 6.94% and a net margin of 6.00%.
View Electromed's earnings history
.

What price target have analysts set for ELMD?

2 brokerages have issued 12-month price targets for Electromed's shares. Their forecasts range from $20.00 to $20.00. On average, they anticipate Electromed's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 58.1% from the stock's current price.
View analysts' price targets for Electromed
or view top-rated stocks among Wall Street analysts.

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Kathleen S. Skarvan, President, Chief Executive Officer & Director
  • Michael J. MacCourt, Chief Financial Officer, Secretary & Treasurer
  • Kristine Owata, Vice President-Reimbursement & Payer Relations

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $12.65.

How much money does Electromed make?

Electromed has a market capitalization of $108.41 million and generates $35.76 million in revenue each year. The medical equipment provider earns $2.36 million in net income (profit) each year or $0.25 on an earnings per share basis.

How many employees does Electromed have?

Electromed employs 120 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

Where are Electromed's headquarters?

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at (952) 758-9299, via email at [email protected], or via fax at 866-758-5077.


This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.